Furthermore, ARID1A-mutated (herein referred to as ARID1Amut) bladder cancers expressed high levels of EZH2, consistent with previous findings that EZH2 expression is upregulated in bladder cancer (17) (Supplemental Figure 1B). This evidence concerns the gene ARID1A and urinary bladder cancer.